Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Treatment of MRSA Wound Infections

Introduction to Treatment

  • The Infectious Diseases Society of America recommends treatment with clindamycin for 7-14 days for MRSA wound infections, with the duration individualized based on the patient's clinical response 1, 2, 3

Treatment Approach Based on Wound Complexity

  • For outpatient treatment of uncomplicated MRSA skin and soft tissue infections, clindamycin 600 mg orally three times daily is an effective option, providing coverage for both MRSA and beta-hemolytic streptococci 2, 3
  • Treatment duration should be 5-10 days for uncomplicated infections, adjusted based on clinical response, according to the Infectious Diseases Society of America 3
  • Clindamycin is suitable as monotherapy for MRSA wound infections due to its coverage of both MRSA and beta-hemolytic streptococci 1

Complicated MRSA Wound Infections

  • For complicated SSTIs, clindamycin 600 mg IV/PO three times daily is recommended, with treatment duration of 7-14 days, adjusted based on clinical response, as suggested by the Infectious Diseases Society of America 1, 2
  • Surgical debridement is essential alongside antibiotic therapy for abscesses and complicated infections, according to the Infectious Diseases Society of America 3

Special Considerations

  • For hospitalized children with complicated MRSA SSTIs, clindamycin 10-13 mg/kg/dose IV every 6-8 hours is recommended if local resistance rates are low, as per the Infectious Diseases Society of America 2, 3
  • Tetracyclines should not be used in children under 8 years of age, as recommended by the Infectious Diseases Society of America 1

Alternative Treatment Options

  • If clindamycin cannot be used, alternatives include trimethoprim-sulfamethoxazole, linezolid, doxycycline or minocycline, and vancomycin IV for severe infections requiring hospitalization, as suggested by the Infectious Diseases Society of America 1, 2, 3

Monitoring and Follow-up

  • Clinical reassessment within 48-72 hours is essential to ensure appropriate response to therapy, according to the Infectious Diseases Society of America 1
  • Cultures from abscesses and purulent SSTIs are recommended in patients treated with antibiotics to confirm the causative organism and guide therapy, as recommended by the Infectious Diseases Society of America 1

Prevention of Recurrence

  • Keeping draining wounds covered with clean, dry bandages, maintaining good personal hygiene, avoiding reusing or sharing personal items, and focusing cleaning efforts on high-touch surfaces can help prevent recurrence of MRSA infections, as suggested by the Infectious Diseases Society of America 1
  • Consideration of decolonization strategies for patients with recurrent MRSA infections is recommended, according to the Infectious Diseases Society of America 1